Repetitive transcranial magnetic stimulation (rTMS) of the brain is a noninvasive, well-tolerated technique that can modify cerebral cortex ... rTMS for motor function in Parkinson disease ...

Now, using a novel system developed at Janelia, researchers led by the Dudman Lab found that a part of the basal ganglia called the striatum is not involved in action selection as previously thought.

The primary endpoint was ... injuries in people living with Parkinson's disease. Pirepemat is designed to strengthen nerve cell signaling in the prefrontal cortex via antagonism at 5HT7 and ...

GOTHENBURG, SE / ACCESS Newswire / March 5, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)(Nasdaq Stockholm:IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, t ...

9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease ... by their primary care physician ...

Galifianakis, MD, while testing a deep brain stimulation treatment for Parkinson's disease. Photo by Maurice Ramirez Starting ... developed and test even newer aDBS algorithms for treating motor ...

Background: Impaired motor inhibition in Parkinson’s disease (PD) is associated with functional alterations in the frontal-basal ganglia (BG) neural circuits. The right dorsolateral prefrontal cortex ...

present brain activity patterns related to complex motor behaviour by combining whole-head magnetoencephalography (MEG) with subthalamic local field potential (LFP) recordings from people with ...

The cerebral cortex and basal ... cortical functions such as motor behavior (Yelnik, 2008). This reciprocal regulation is significantly altered after BG dysfunction, as in neurological disorders such ...

This valuable study combined whole-head magnetoencephalography (MEG) and subthalamic (STN) local field potential (LFP) recordings in patients with ... this was done for two motor cortical regions of ...